Intellipharmaceutics International is engaged in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Co.'s patented Hypermatrix™ technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Based on this technology platform, Co. has developed several drug delivery systems, a pipeline of products and product candidates in various stages of development in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract, diabetes and pain. We show 14 historical shares outstanding datapoints in our IPCI shares outstanding history coverage, used to compute IPCI market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing IPCI market cap history over the course of time is important for investors
interested in comparing IPCI's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of IPCI versus a peer is one thing; comparing
IPCI market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like IPCI can fluctuate over the course of history.
With this page we aim to empower investors researching IPCI by allowing them to research the IPCI market cap history. |
Free IPCI Email Alerts:
Video: The Importance of Market Cap
